The Genetic Factors in the Development of Atrial Fibrillation

Author(s):
Zulfiya   KachiyevaZulfiya KachiyevaZulfiya   Kachiyeva ORCID1, Aiganym TolegenkyzyAiganym Tolegenkyzy1, Timur  SalievTimur SalievTimur  Saliev ORCID1, Shynar TanabayevaShynar TanabayevaShynar Tanabayeva ORCID1, Baimakhan Tanabayev Baimakhan Tanabayev Baimakhan Tanabayev  ORCID2, Bakhyt RamazanovaBakhyt RamazanovaBakhyt Ramazanova ORCID1, Ildar FakhradiyevIldar FakhradiyevIldar Fakhradiyev ORCID1,*
1S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
2South-Kazakhstan Medical Academy, Shymkent, Kazakhstan

International Cardiovascular Research Journal:Vol. 15, issue 1; e108440
Published online:Mar 15, 2021
Article type:Review Article
Received:Aug 10, 2020
Accepted:Nov 14, 2020
How to Cite:Kachiyeva Z, Tolegenkyzy A, Saliev T, Tanabayeva S, Tanabayev B, et al. The Genetic Factors in the Development of Atrial Fibrillation. Int Cardiovasc Res J. 2021;15(1):e108440. doi:

Abstract

Fulltext

 
 
The full-text is available in pdf.
 
 
 
 
 
 
 

References

  • 1.
    The references are available in pdf.

Similar Articles

1
Dec
2014

Focal Treatment for Genetic Disorders (A Fairy Tale or a True Story?)

Mohammad hossein Nikoo,
Mohammad Vahid Jorat,
Amir Aslani

Nikoo MH, Jorat MV, Aslani A. Focal Treatment for Genetic Disorders (A Fairy Tale or a True Story?). Int Cardiovasc Res J. 2017;8(4):e11673. doi:

12
Aug
2018
http://genecelltissue.com/en/articles/74203.html

Gene-Finding Strategy in Glaucoma

Mehrnaz Narooie-Nejad

Narooie-Nejad M. Gene-Finding Strategy in Glaucoma. Gene Cell Tissue. 2018;5(2):e74203. doi: https://doi.org/10.5812/gct.74203

7
May
2019

9P21.3 locus; An Important Region in Coronary Artery Disease: A Panel Approach to Investigation of the Coronary Artery Disease Etiology

Soodeh Omidi,
Fatemeh Ebrahimzadeh,
Samira Kalayinia

Omidi S, Ebrahimzadeh F, Kalayinia S. 9P21.3 locus; An Important Region in Coronary Artery Disease: A Panel Approach to Investigation of the Coronary Artery Disease Etiology. Int J Cardiovasc Pract. 2019;4(2):e130551. doi: https://doi.org/10.29252/ijcp-25001

25
Dec
2017

CYP2C9*1*2 and VKORC1-1639 AA Polymorphisms Correlation with Warfarin Dose Requirement: A Case Report

Zohreh Hoseinkhani,
Reza Khodarahmi,
Mona Sadeghalvad,
Fathemeh Norooznezhad,
Kamran Mansouri

Hoseinkhani Z, Khodarahmi R, Sadeghalvad M, Norooznezhad F, Mansouri K. CYP2C9*1*2 and VKORC1-1639 AA Polymorphisms Correlation with Warfarin Dose Requirement: A Case Report. J Rep Pharm Sci. 2018;7(1):e147605. doi:

29
Mar
2024
J Crit Care Excell

Clustering Patients with Paroxysmal Atrial Fibrillation

Behrooz Farzanegan,
Nasser Malekpour Alamdari,
Navid Nuraei,
Mohammad Fathi

Farzanegan B, Malekpour Alamdari N, Nuraei N, Fathi M. Clustering Patients with Paroxysmal Atrial Fibrillation. J Crit Care Excell. 2024;1(1):e148597. doi: https://doi.org/10.5812/jcce-148597

Indexed in
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles